Featured Story | By Heather Landi There were reports earlier this month that concierge primary care company One Medical was looking at potential suitors for a takeover deal. It seems Amazon made the right offer. read more |
| |
|---|
|
Top Stories By Kevin Dunleavy Leading Roche’s successful effort to develop COVID-19 test kits helped solidify Thomas Schinecker’s status as the company’s heir apparent to the CEO post. On Thursday, the Swiss pharma powerhouse made it official. read more By Andrea Park According to the DOJ, many of the fraudulent telemedicine referrals included orders for expensive genetic tests for cardiovascular conditions and cancer. read more By James Waldron Roche has halted five early and midstage trials covering a range of cancer, asthma and metabolic disease drugs. Looking to the future, the Swiss pharma admits that two of its most exciting prospects remain high-risk. read more By Zoey Becker The years-long saga of the U.K. competition authority's probe into Pfizer and Flynn Pharma's pricing strategy for epilepsy drug Epanutin came to a head with a combined fine of £70 million pounds. read more By Conor Hale After expanding the use of its artificial intelligence programs for guiding U.S. clinicians through ultrasound exams of the heart, Caption Health is taking its software overseas with its first green light in Europe. read more By Max Bayer The former global head of R&D for GSK's vaccine division has found a new gig, taking the CEO role at a newly-launched biotech slated to directly challenge the British Big Pharma. The new venture, Vicebio, hopes to launch an RSV shot into the clinic in the second half of 2023. read more By Dave Muoio “External forces” of workforce shortages, inflation and supply chain disruptions have led the Catholic health system to consolidate its leadership and operating structure. "Essential roles" such as nurses, however, will remain intact. read more By Andrea Park Several months into its cost-cutting quest, Acutus is beginning to reap the rewards of its slimmed-down business and has appointed a new CEO—effective Thursday—to help navigate its next moves. read more By Annalee Armstrong The end of the second quarter sparked a flurry of layoffs across the biotech industry, and X4 Pharmaceuticals is the latest to show staff the door. read more By Fraiser Kansteiner WuXi Bio is laying out $1.4 billion over the next 10 years to beef up research and development, plus large-scale drug substance and drug product manufacturing in Singapore. The upgrade is expected to add 120,000 liters of biomanufacturing capacity to the company’s global network by 2026. read more By Robert King The Justice Department cracked down on a series of schemes aimed at bilking Medicare out of $1.2 billion via telehealth and testing fraud. read more Resources Sponsored by: NetApp Could cloud be the cure for your EHR headaches? See our infographic on how moving to the cloud can slash financial and administrative burdens. Sponsored by: Cognizant Explore how Cognizant SIP helped Roche streamline its global feasibility process. Sponsored by: Blue Matter Consulting This e-book covers the 12 most common pitfalls for companies entering European markets for the first time, offering guidance to help growing companies avoid them and succeed. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Thermo Fisher Scientific The journey for starting or expanding a lab can be exhilarating, while also being challenging--learn how this free program provides savings and solutions to support your goals. Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Carla Vozone discusses the significant trends in the OINDP segment including large molecules and novel indications, changes within CDMOs and various challenges facing the industry. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. | 
